SEC Form 4 · accession 0001209191-16-114344
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lewis T Williams
Officer — President, CEO and Chairman · Director
Period of report
Apr 14, 2016
Accepted (ET)
Apr 15, 2016 · 2:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 14, 2016 | M | 2,725 | $8.49 | A | 343,253 | D | |
| Common Stock | Apr 14, 2016 | S | 2,725 | $48.00 | D | 340,528 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $8.49 | Apr 14, 2016 | M | 2,725 | A | — | Oct 19, 2021 | Common Stock | 2,725 | 66,425 | D |
Explanation of responses
- F1The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on November 4, 2015.
- F2This option is fully vested and immediately exercisable.